Article
Effects of C358A missense polymorphism of the endocannabinoid degrading enzyme fatty acid amide hydrolase on weight loss and cardiovascular risk factors 1 year after biliopancreatic diversion surgery.
Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery - 1 Jan 2000
de Luis D A, Sagrado M Gonzalez, Pacheco D, Terroba M C, Martin T, Cuellar L, Ventosa M
Abstract excerpt
BACKGROUND: Bariatric surgery is the most effective long-term treatment of morbid obesity and also results in a reduction of obesity-associated co-morbidities. We investigated the role of the polymorphism (C358A) of the fatty acid amide hydrolase gene on the clinical outcomes 1 year after biliopancreatic diversion in morbidly obese patients. METHODS: A total of 67 morbidly obese patients (body mass index >40...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.